Journal article
Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data
Z Ademi, D Liew, A Gorelik, M Bohensky, E Zomer, B Hollingsworth, G Steg, DL Bhatt, CM Reid
International Journal of Cardiology | ELSEVIER IRELAND LTD | Published : 2014
Abstract
Background Atherothrombotic diseases are the leading health problems in the world, both in terms of morbidity and mortality. This study aimed to identify and quantify the predictors of medication, hospital and outpatient service use among patients with or at high risk of atherothrombotic disease. Methods Two-year follow-up data were analyzed for 2873 Australian participants of the Reduction of Atherothrombosis for Continued Health (REACH) registry. The analysis was performed using generalized linear models with Poisson and Gamma distributions and log link function. Results Participants with hypercholesterolemia, diabetes, hypertension, atrial fibrillation (AF), and history of coronary artery..
View full abstractGrants
Awarded by Bristol-Myers Squibb
Funding Acknowledgements
The global REACH Registry is sponsored by Sanofi-Aventis, Bristol-Myers Squibb and the Waksman Foundation (Tokyo, Japan), and is endorsed by the World Heart Federation. The REACH Registry enforces a no-ghost-writing policy. The sponsors provide logistical support. All manuscripts in the REACH Registry are led by independent authors who are not governed by the funding sponsors and are reviewed by an academic publication committee before submission. The funding sponsors have the opportunity to review manuscript submissions but do not have authority to change any aspect of a manuscript. A complete list of the REACH Registry Investigators appears in JAMA. 2006; 295(2): 180-189.